Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

J&J’s Covid-19 vaccine prevents severe disease in preclinical tests

pharmaceutical-technologySeptember 04, 2020

Tag: COVID-19 vaccine , Johnson & Johnson , Janssen , SARS-CoV-2

PharmaSources Customer Service